Glaxosmithkline Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Glaxosmithkline Pharmaceuticals is trading 1.19% upper at Rs 2,683.00 as compared to its last closing price. Glaxosmithkline Pharmaceuticals has been trading in the price range of 2,683.70 & 2,615.25. Glaxosmithkline Pharmaceuticals has given 39.67% in this year & -3.98% in the last 5 days.
Glaxosmithkline Pharmaceuticals has TTM P/E ratio 70.18 as compared to the sector P/E of 32.38.There are 4 analysts who have initiated coverage on Glaxosmithkline Pharmaceuticals. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 182.33 Crores in its last quarter.
Listed peers of Glaxosmithkline Pharmaceuticals include Abbott India (2.76%), Glenmark Pharmaceuticals (0.26%), Glaxosmithkline Pharmaceuticals (1.19%) etc.
Glaxosmithkline Pharmaceuticals has a 25.00% public holding.The Mutual Fund holding in Glaxosmithkline Pharmaceuticals was at 2.27% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Glaxosmithkline Pharmaceuticals was at 4.36% in 30 Sep 2024. The FII holding has increased from the last quarter.
Glaxosmithkline Pharmaceuticals share price range
|
| ||||
|
| ||||
Glaxosmithkline Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 44,912.08 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Glaxosmithkline Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 02-Aug-24 | Quarterly Results |
| 17-May-24 | Audited Results & Final Dividend |
| 12-Feb-24 | Quarterly Results |
| 09-Nov-23 | Quarterly Results |
| 26-Jul-23 | Quarterly Results |
| 17-May-23 | Audited Results & Final Dividend |
| 07-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results |
| 25-Jul-22 | Quarterly Results |
| 16-May-22 | Audited Results & Dividend |
| Meeting Date | Announcement On | Purpose |
| 26-Jul-23 | 17-May-23 | AGM |
| 26-Jul-22 | 16-May-22 | AGM |
| 23-Apr-22 | 22-Mar-22 | POM |
| 27-Jul-21 | 18-May-21 | AGM |
| 29-May-21 | 27-Apr-21 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 17-May-24 | 31-May-24 | 31-May-24 | 32 |
| 17-May-23 | 30-Jun-23 | 30-Jun-23 | 32 |
| 16-May-22 | 08-Jul-22 | 07-Jul-22 | 30 |
| 17-May-22 | 08-Jul-22 | 07-Jul-22 | 60 |
| 18-May-21 | 20-Jul-21 | 19-Jul-21 | 30 |
FAQs about Glaxosmithkline Pharmaceuticals share price
Glaxosmithkline Pharmaceuticals is trading at 2683.00 as on Fri Oct 18 2024 09:59:50. This is 1.19% upper as compared to its previous closing price of 2651.45.
The market capitalization of Glaxosmithkline Pharmaceuticals is 45451.64 Cr as on Fri Oct 18 2024 09:59:50.
The average broker rating on Glaxosmithkline Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 2 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Glaxosmithkline Pharmaceuticals is 3087.95 whereas the 52 wk low is 1387.90
Glaxosmithkline Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 70.18
- Sector P/E: 32.38
- Dividend Yield: 1.21%
- D/E ratio: -
Glaxosmithkline Pharmaceuticals reported a net profit of 589.96 Cr in 2024.
Glaxosmithkline Pharmaceuticals Quick Links
Glaxosmithkline Pharmaceuticals Dividend Glaxosmithkline Pharmaceuticals Bonus Glaxosmithkline Pharmaceuticals News Glaxosmithkline Pharmaceuticals AGM Glaxosmithkline Pharmaceuticals Rights Glaxosmithkline Pharmaceuticals Splits Glaxosmithkline Pharmaceuticals Board Meetings Glaxosmithkline Pharmaceuticals Key Metrics Glaxosmithkline Pharmaceuticals Shareholdings Glaxosmithkline Pharmaceuticals Profit Loss Glaxosmithkline Pharmaceuticals Balance Sheet Glaxosmithkline Pharmaceuticals Cashflow Glaxosmithkline Pharmaceuticals Q1 Results Glaxosmithkline Pharmaceuticals Q2 Results Glaxosmithkline Pharmaceuticals Q3 Results Glaxosmithkline Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks